文献速递肾小球疾病遗传性与小管间质肾病

小分子伴侣c407纠正R138Q突变podocin的异常转运并改善遗传性肾病综合征

A small molecule chaperone rescues keratin-8 mediated trafficking of misfolded podocin to correct genetic Nephrotic Syndrome.
PubMed 文献 · Kidney Int · 2023-11-22

该研究揭示podocin R138Q突变体与角蛋白8(K8)形成复合物,阻碍其正确转运至细胞膜。小分子c407可打断该复合物,在人患者R138Q突变足细胞系和小鼠可诱导R138Q敲入模型中实现podocin正确膜定位及功能挽救。在疾病诱导前经渗透泵或口服给药,以及疾病诱导后两周经渗透泵给药,均完全挽救蛋白尿和组织学改变。

要点

  • podocin R138Q(非野生型)与角蛋白8结合,阻碍其转运至细胞膜。
  • 小分子c407打断podocin R138Q-K8复合物,恢复膜定位和功能。
  • c407在R138Q足细胞系和R138Q敲入小鼠中完全挽救蛋白尿及组织学改变。

核心结论

  • podocin R138Q通过结合角蛋白8导致异常滞留,c407可打断该复合物并挽救转运缺陷。
  • c407在R138Q突变足细胞系和R138Q敲入小鼠中完全挽救蛋白尿和组织学改变。
  • 该数据为携带podocin突变的肾病综合征患者提供了一种治疗选择,并可能适用于其他错误折叠蛋白疾病。

研究设计与样本

  • 研究使用人患者R138Q突变足细胞细胞系和小鼠可诱导R138Q敲入模型。
  • c407分别通过渗透泵或口服给药,在疾病诱导前或诱导后两周给予。

主要发现

  • podocin R138Q(而非野生型podocin)与角蛋白8形成复合物,阻止其正确转运至细胞膜。
  • c407打断该复合物,使podocin正确定位于细胞膜并在人R138Q突变足细胞系和R138Q敲入小鼠中实现功能挽救。
  • 在疾病诱导前经渗透泵或口服给予c407,以及在疾病诱导后两周经渗透泵给予c407,均完全挽救蛋白尿和组织学改变。

临床怎么用

  • 对于携带podocin R138Q突变的遗传性肾病综合征患者,c407可能成为纠正蛋白错误转运的候选治疗药物。
  • c407在疾病诱导后两周给药仍显示完全挽救效果,提示其可能具有治疗时间窗。
  • 原文指出需进一步研究确认这些发现。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Podocin is a key membrane scaffolding protein of the kidney podocyte essential for intact glomerular filtration. Mutations in NPHS2, the podocin-encoding gene, represent the commonest form of inherited nephrotic syndrome (NS), with early, intractable kidney failure. The most frequent podocin gene mutation in European children is R138Q, causing retention of the misfolded protein in the endoplasmic reticulum. Here, we provide evidence that podocin R138Q (but not wild-type podocin) complexes with the intermediate filament protein keratin 8 (K8) thereby preventing its correct trafficking to the plasma membrane. We have also identified a small molecule (c407), a compound that corrects the Cystic Fibrosis Transmembrane Conductance Regulator protein defect, that interrupts this complex and rescues mutant protein mistrafficking. This results in both the correct localization of podocin at the plasma membrane and functional rescue in both human patient R138Q mutant podocyte cell lines, and in a mouse inducible knock-in model of the R138Q mutation. Importantly, complete rescue of proteinuria and histological changes was seen when c407 was administered both via osmotic minipumps or delivered orally prior to induction of disease or crucially via osmotic minipump two weeks after disease induction. Thus, our data constitute a therapeutic option for patients with NS bearing a podocin mutation, with implications for other misfolding protein disorders. Further studies are necessary to confirm our findings.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Kuzmuk V, Pranke I, Rollason R, et al. A small molecule chaperone rescues keratin-8 mediated trafficking of misfolded podocin to correct genetic Nephrotic Syndrome. Kidney Int. 2023. PMID: 37995908. doi:10.1016/j.kint.2023.11.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。